A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma

被引：2
|
作者：
Kalac, Matko [1 ]
Tam, Constantine Si Lun [2 ]
Goldfinger, Mendel [3 ]
Xiao, Zhengrui [4 ]
Montanari, Francesca [5 ]
Kanakry, Jennifer A. [6 ]
O'Connor, Owen [7 ]
Marchi, Enrica [8 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Oncol, Div Hematol Malignancies, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, New York, NY USA
[5] Yale Sch Med, Greenwich, CT USA
[6] NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
[7] Univ Virginia, Div Hematol Oncol, Program T Cell Lymphoma Res, Charlottesville, VA USA
[8] Univ Virginia, Program T Cell Lymphoma Res, Charlottesville, VA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-144651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4550
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
    Kalac, Matko
    Jain, Salvia
    Tam, Constantine S.
    Xiao, Zhengrui
    Montanari, Francesca
    Kanakry, Jennifer
    Huber, Bryan D.
    Goldfinger, Mendel
    O'Connor, Owen A.
    Marchi, Enrica
    BLOOD ADVANCES, 2023, 7 (14) : 3760 - 3763
  • [2] A real-world experience of combined treatment with romidepsin and azacitidine in patients with peripheral T-cell lymphoma.
    Kalac, Matko
    Tam, Constantine Si Lun
    Goldfinger, Mendel
    Xiao, Zhengrui
    Rajeeve, Sridevi
    Montanari, Francesca
    Kanakry, Jennifer Ann
    O'Connor, Owen
    Marchi, Enrica
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] A Real World Experience of Combined Treatment with Romidepsin and Azacitidine in Patients with Peripheral T-Cell Lymphoma - a Bridge to Transplant and an Effective Salvage for the Unfit
    Kalac, Matko
    Jain, Salvia
    Tam, Constantine S.
    Goldfinger, Mendel
    Xiao, Zhengrui
    Montanari, Francesca
    Huber, Bryan D.
    Kanakry, Jennifer A.
    O'Connor, Owen A.
    Marchi, Enrica
    BLOOD, 2022, 140 : 9422 - 9424
  • [4] Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
    Iyer, Swaminathan P.
    Foss, Francine F.
    ONCOLOGIST, 2015, 20 (09): : 1084 - 1091
  • [5] Romidepsin for peripheral T-cell lymphoma
    Khot, Amit
    Dickinson, Michael
    Prince, H. Miles
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 351 - 359
  • [6] Long-Term Treatment with Romidepsin in Patients with Peripheral T-Cell Lymphoma
    Irle, Claudius
    Weintraub, Jonathan
    CASE REPORTS IN HEMATOLOGY, 2016, 2016
  • [7] Romidepsin In the Treatment of T-Cell Lymphoma
    Yang, Lily P. H.
    DRUGS, 2011, 71 (11) : 1469 - 1480
  • [8] Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
    Woo, Sukyung
    Gardner, Erin R.
    Chen, Xiaohong
    Ockers, Sandra B.
    Baum, Caitlin E.
    Sissung, Tristan M.
    Price, Douglas K.
    Frye, Robin
    Piekarz, Richard L.
    Bates, Susan E.
    Figg, William D.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1496 - 1503
  • [9] Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
    Piekarz, Richard L.
    Frye, Robin
    Prince, H. Miles
    Kirschbaum, Mark H.
    Zain, Jasmine
    Allen, Steven L.
    Jaffe, Elaine S.
    Ling, Alexander
    Turner, Maria
    Peer, Cody J.
    Figg, William D.
    Steinberg, Seth M.
    Smith, Sonali
    Joske, David
    Lewis, Ian
    Hutchins, Laura
    Craig, Michael
    Fojo, A. Tito
    Wright, John J.
    Bates, Susan E.
    BLOOD, 2011, 117 (22) : 5827 - 5834
  • [10] Romidepsin in the treatment of cutaneous T-cell lymphoma
    Jain, Salvia
    Zain, Jasmine
    JOURNAL OF BLOOD MEDICINE, 2011, 2 : 37 - 47
12345